Dr Evangelia Yannaki, Special Haematologist & Director at HCT Unit G. Papanicolaou Hospital, Greece, discusses the current status and results of gene therapy for patients with transfusion-dependent β-thalassaemia (TDT).
This live interview was featured on Greek TV Station, Mega Channel, on June 17, 2020.
English subtitles are embedded.
![](https://i.ytimg.com/vi/i1FuWcNzILg/maxresdefault.jpg)